Serum peripherin as a disease biomarker in hereditary transthyretin amyloidosis: a multicenter cohort study
This study demonstrates that serum peripherin represents a promising biomarker for early detection of PNS damage in ATTRv, with elevated levels detectable even in presymptomatic stages.
Authors
- Stefano Tozza (ORCID: https://orcid.org/0000-0002-9672-4577)
- Angela Stufano (ORCID: https://orcid.org/0000-0002-9101-7742)
- Nicola De Stefano (ORCID: https://orcid.org/0000-0003-4930-7639)
- Valeria Guglielmino (ORCID: https://orcid.org/0000-0002-9049-5988)
- Carlo Manco (ORCID: https://orcid.org/0000-0003-4572-2616)
- Guido Primiano (ORCID: https://orcid.org/0000-0001-7616-7008)
- Andrea Sabino (ORCID: https://orcid.org/0009-0007-5257-374X)
- Maria Laura Stromillo
- Francesca Forcina (ORCID: https://orcid.org/0009-0002-2572-5801)
- Paolo Calabresi (ORCID: https://orcid.org/0000-0003-0326-5509)
- Maria Ausilia Sciarrone (ORCID: https://orcid.org/0000-0002-1490-0320)
- Luca Leonardi (ORCID: https://orcid.org/0000-0003-3223-3901)
- Marco Ceccanti
- F Manganelli
- Domenico Plantone
- Delia Righi
- Angela Romano
- Marco Luigetti
- Maurizio Inghilleri
- Francesca Vitali
Institutions
- University of Siena (IT)
- Università Cattolica del Sacro Cuore (IT)
- University of Foggia (IT)
- Agostino Gemelli University Polyclinic (IT)
- Istituto Neurologico Mediterraneo (IT)
- CTO Andrea Alesini (IT)
- Federico II University Hospital (IT)
- Azienda Ospedaliera Sant'Andrea (IT)
- University of Naples Federico II (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Amyloid
- Published
- 2026-03-16
- DOI
- https://doi.org/10.1080/13506129.2026.2640984
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00